Screener
Relay Therapeutics, Inc. RLAY Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 91,174 | 77,524 | 172,764 | 170,072 |
| Loss from operations | (90,824) | (76,847) | (169,414) | (161,717) |
| Other income: | ||||
| Interest income | 7,115 | 7,105 | 12,467 | 14,918 |
| Other income (expense) | 2 | (633) | (51) | (641) |
| Total other income, net | 7,117 | 6,472 | 12,416 | 14,277 |
| Net loss | $(83,707) | $(70,375) | $(156,998) | $(147,440) |
| Net loss per share, basic and diluted | $(0.41) | $(0.41) | $(0.82) | $(0.87) |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s interest income?
- Relay Therapeutics, Inc. (RLAY) reported interest income of $7.12M in Q2 2026.
- How has Relay Therapeutics, Inc.'s interest income changed year-over-year?
- Relay Therapeutics, Inc.'s interest income increased by 0.1% year-over-year, from $7.11M to $7.12M.
- What is the long-term trend for Relay Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s interest income has grown at a 138.9% compound annual growth rate (CAGR), from $830K to $27.04M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Relay Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude